FBR & Co. restated their outperform rating on shares of The Advisory Board Company (NASDAQ:ABCO) in a research report report published on Tuesday, AnalystRatingsNetwork.com reports. They currently have a $55.00 target price on the stock.

In other The Advisory Board Company news, General Counsel Evan R. Farber sold 2,837 shares of the stock in a transaction dated Friday, November 20th. The stock was sold at an average price of $51.81, for a total value of $146,984.97. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Hoose Mary Van sold 3,700 shares of the stock in a transaction dated Friday, November 20th. The stock was sold at an average price of $51.12, for a total value of $189,144.00. Following the transaction, the insider now owns 30,956 shares of the company’s stock, valued at $1,582,470.72. The disclosure for this sale can be found here.

Several hedge funds and institutional investors have recently bought and sold shares of ABCO. Franklin Street Advisors increased its position in The Advisory Board Company by 18.6% in the fourth quarter. Franklin Street Advisors now owns 27,850 shares of the company’s stock worth $1,382,000 after buying an additional 4,375 shares during the last quarter. Douglas C. Lane & Associates Inc. increased its position in The Advisory Board Company by 3.4% in the fourth quarter. Douglas C. Lane & Associates Inc. now owns 464,514 shares of the company’s stock worth $23,045,000 after buying an additional 15,386 shares during the last quarter. Janus Capital Management increased its position in The Advisory Board Company by 15.3% in the third quarter. Janus Capital Management now owns 479,598 shares of the company’s stock worth $21,841,000 after buying an additional 63,603 shares during the last quarter. Finally, Eagle Asset Management increased its position in The Advisory Board Company by 91.5% in the third quarter. Eagle Asset Management now owns 1,786,488 shares of the company’s stock worth $81,356,000 after buying an additional 853,627 shares during the last quarter.

The Advisory Board Company (NASDAQ:ABCO) opened at 43.24 on Tuesday. The company’s 50-day moving average price is $47.89 and its 200-day moving average price is $49.47. The firm’s market capitalization is $1.81 billion. The Advisory Board Company has a 12-month low of $40.70 and a 12-month high of $60.38.

The Advisory Board Company (NASDAQ:ABCO) last posted its quarterly earnings data on Thursday, November 5th. The company reported $0.33 EPS for the quarter, topping analysts’ consensus estimates of $0.14 by $0.19. During the same period in the prior year, the firm posted $0.43 EPS. The business earned $200.20 million during the quarter, compared to analyst estimates of $188.88 million. The Advisory Board Company’s revenue for the quarter was up 38.8% compared to the same quarter last year. Equities analysts expect that The Advisory Board Company will post $1.35 EPS for the current fiscal year.

A number of other equities analysts have also commented on the company. JPMorgan Chase & Co. assumed coverage on The Advisory Board Company in a research note on Tuesday, November 17th. They issued an overweight rating and a $64.00 price objective on the stock. Cantor Fitzgerald assumed coverage on The Advisory Board Company in a research note on Monday, November 9th. They issued a buy rating and a $60.00 price objective on the stock. Zacks Investment Research lowered The Advisory Board Company from a buy rating to a hold rating in a research note on Monday, November 9th. Raymond James reduced their price objective on The Advisory Board Company from $64.00 to $57.00 and set an outperform rating on the stock in a research note on Friday, November 6th. Finally, Canaccord Genuity reissued a buy rating and issued a $63.00 price objective (down previously from $65.00) on shares of The Advisory Board Company in a research note on Friday, November 6th. One analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. The company currently has a consensus rating of Buy and a consensus target price of $61.15.

The Advisory Board Company is a provider of software and solutions to the healthcare and higher education industries. The Company’s healthcare programs address a range of clinical and business issues, including physician alignment and engagement, network management and growth strategy, value-based care and population health, revenue cycle, clinical operations and supply chain. Its higher education programs support colleges and universities in enrollment management, academic programming and student learning, faculty recruitment and retention, student advising and success, alumni affairs and advancement, and college and university operations. The Company offers approximately 65 distinct membership programs, across four areas, which include best practices research and insight, performance technology software, consulting and management services, and data- and tech-enabled services. Its best practices research and insight programs provide the foundation for all of its other programs.

12 Month Chart for NASDAQ:ABCO

Frustrated with your broker? Are you tired of paying high fees? Do you feel like you are getting ripped off by your stock broker? It's time for a change. Find out which brokerage is best for your personal trading style at the InvestorPlace Broker Center. Compare brokers at a glance in the InvestorPlace Broker Center (Click Here).

Receive News & Ratings for The Advisory Board Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Advisory Board Company and related companies with MarketBeat.com's FREE daily email newsletter.